| 000 | 00909nam a2200229 ib4500 | ||
|---|---|---|---|
| 001 | D0001J001049 | ||
| 003 | DOH | ||
| 005 | 20240708171550.0 | ||
| 008 | 240708s ||||| |||| 00| 0 eng d | ||
| 100 | 1 | _aRuppe, Etienne | |
| 245 | 0 | 0 |
_aLessons from a global antimicrobial resistance surveillance network / _cBy: Etienne Ruppe, Network for Enhancing Tricycle ESBL Surveillance Efficiency (NETESE) group |
| 580 | _aBulletin of the World Health Organization 2023, 101(10) 672-678 | ||
| 650 | 0 | 1 |
_aAnti-Bacterial Agents _vpharmacology |
| 650 | 0 | 1 |
_aAnti-Bacterial Agents _vtherapeutic use |
| 650 | 0 | 1 | _aDrug Resistance, Bacterial |
| 650 | 0 | 1 | _aEscherichia coli |
| 650 | 0 | 1 |
_aEscherichia coli Infections _vepidemiology |
| 650 | 0 | 1 |
_aEscherichia coli Infections _vmicrobiology |
| 650 | 0 | 1 | _abeta-Lactamases |
| 710 | 2 | _aNetwork for Enhancing Tricycle ESBL Surveillance Efficiency (NETESE) group | |
| 942 | _cJA | ||
| 999 |
_c6402 _d6402 |
||